Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer [Phase 4]
Phase 4 clinical trial evaluating quality of life after biliodigestive anastomosis or stents for biliary obstruction in pancreatic cancer; s…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes [Phase 2]
Phase 2 trial evaluating intravenous human albumin to improve outcomes after pancreaticoduodenectomy, including pancreatic fistula and relat…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating induction FOLFIRINOX followed by chemoradiation for locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer [Phase 1, Phase 2]
Phase 1/2 trial of M7824 (immune checkpoint inhibitor) and M9241 (immunocytokine) with SBRT in adults with advanced pancreatic cancer; study…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer [Phase 2]
Phase II trial evaluating BI 2536, a PLK-1 inhibitor, in advanced, unresectable pancreatic cancer has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-26Clinical Trial Update: A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer. [Phase 2]
Phase 2 exploratory trial evaluating sintilimab with albumin-bound paclitaxel and gemcitabine for unresectable locally advanced pancreatic c…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC [Phase 1, Phase 2]
Open-label Phase I/II trial evaluating the PLENA regimen for unresectable pancreatic cancer or biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating whether thromboprophylaxis impacts progression-free survival in advanced pancreatic cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial exploring Envafolimab in combination with Endostar and chemotherapy as first-line treatment for advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical study of VG161 in combination with nivolumab in advanced pancreatic cancer across Phase 1 and Phase 2 stages.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Electroporation Potentiated Immunotherapy in Cancer [Phase 2]
Phase 2 trial update evaluating electroporation-potentiated immunotherapy in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine/capecitabine followed by SBRT in pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating S-1 plus gemcitabine versus gemcitabine alone as adjuvant therapy after pancreatic cancer resection.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer [Phase 2]
Phase II trial investigating Fruquintinib as third-line treatment for advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: High-dose Vitamin D3 in Pancreas Cancer [Phase 3]
Phase 3 trial of high-dose Vitamin D3 in pancreas cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
Clinical trial investigating predictors of tumor response and radiation therapy side effects in gastrointestinal cancers; terminated with po…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of avelumab, binimetinib, and talazoparib in locally advanced or metastatic RAS-mutant solid tumors was terminated; results …
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients [Phase 2]
A Phase 2 clinical trial update evaluating first-line treatment with fruquintinib plus albumin paclitaxel and gemcitabine in pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab [Phase 2]
Phase 2 single-patient protocol trial update for seribantumab in an NRG1 fusion-positive metastatic pancreatic cancer patient; study complet…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluated nab-paclitaxel and gemcitabine with or without the angiogenesis-targeting antibody olaratumab in metast…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial of SHR6390 with nab-paclitaxel and gemcitabine in advanced/metastatic pancreatic cancer is underway with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body [NA]
Clinical trial update on neoadjuvant stereotactic body radiation therapy for resectable pancreatic head/body adenocarcinoma; study completed…
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluated entinostat in combination with nivolumab in patients with previously treated unresectable or metastatic cholangioc…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating intensified neoadjuvant chemotherapy for locally advanced pancreatic cancer has completed.